Skip Ribbon Commands
Skip to main content
Dr Tu Tian Ming

Dr Tu Tian Ming

​MBBS, MRCP (United Kingdom), MCI (NUS)

Senior Consultant

National Neuroscience Institute

Specialty: Neurology, Neurology

Sub-specialties: Stroke, General Neurology

Conditions Treated by this Doctor:

Clinical Appointments

  • Senior Consultant Department of Neurology National Neuroscience InstituteNational Neuroscience Institute
  • Senior Consultant NNI @CGH Changi General HospitalChangi General Hospital


​Dr Tu Tian Ming is a Senior Consultant at the National Neuroscience Institute and a clinic tutor at the Yong Loo Lin School of Medicine.

Dr Tu completed his undergraduate medical training at the National University of Singapore in 2005 and obtained his membership with the Royal College of Physicians (UK) in 2010. He completed his neurology advanced specialist training at the National Neuroscience Institute in 2014. Additionally, Dr Tu also completed a Masters in Clinical Investigation at the National University of Singapore in 2015 as well as an overseas research fellowship supported by the National Medical Research Council of Singapore at Duke University, USA in 2016.

Dr Tu’s clinical and research interest is in acute ischemic stroke and neuro-critical care.


Overseas Research Fellowship, Duke University, 2015 - 2016

MBBS (Singapore), 2005

Professional Appointments and Committee Memberships

  • Senior Consultant, Department of Neurology, National Neuroscience Institute
  • Clinical Tutor, Yong Loo Lin School of Medicine
  • Member, American Academy of Neurology
  • Member, Stroke Council, American Heart Association
  • Member, Singapore National Stroke Association


  • Ministry of Health Healthcare Research Scholarship Award, 2013
  • Junior Doctor Teaching Award, Yong Loo Lin School of Medicine, AY2013/2014
  • Outstanding Tutor Award, Yong Loo Lin School of Medicine, AY2014/2015
  • Ministry of Health Overseas Research Fellowship Award, 2015
  • SingHealth 10 Years Long Service Award, 2017

Research Interests

  • Acute Ischemic Stroke
  • Neuro-critical Care


  • ​Apolipoprotein E mimetic peptide, CN-105, improves outcomes in ischemic stroke. Tu, T. M., Kolls, B. J., Soderblom, E. J., Cantillana, V., Ferrell, P. D., Moseley, M. A., Wang, H., Dawson, H. N. and Laskowitz, D. T. 2017, Ann Clin Transl Neurol. doi:10.1002/acn3.399
  • Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects. Guptill JT, Raja SM, Boakye-Agyeman F, Noveck R, Ramey S, Tu TM, Laskowitz DT. J Clin Pharmacol. 2016 Dec 19. doi: 10.1002/jcph.853.
  • The quest to prevent stroke in atrial fibrillation: fighting the fluttering heart in Singapore. Goh O, Lai G, Tu TM, Lee KE. Neurology. 2014 Jun 3;82(22):2034-6.
  • Clinical risk factors for non-convulsive status epilepticus during emergent electroencephalogram. Tu TM, Loh NK, Tan NC. Seizure. 2013 Nov;22(9):794-7
  • Lymphocytic follicles and aggregates are a determinant of mucosal damage and duration of diarrhea. Shah N, Thakkar B, Shen E, Loh M, Chong PY, Gan WH, Tu TM, Shen L, Soong R, Salto-Tellez M. Arch Pathol Lab Med. 2013 Jan;137(1):83-9.
  • Naturally acquired human Plasmodium knowlesi infection, Singapore. Ng OT, Ooi EE, Lee CC, Lee PJ, Ng LC, Pei SW, Tu TM, Loh JP, Leo YS. Emerg Infect Dis. 2008 May;14(5):814-6.

Research Trials